Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
IPD.AX
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q2.20
N/A
-0.01
vs -0.03
Q4.20
N/A
-0.01
vs -0.03
Q2.21
N/A
-0.01
vs -0.01
Q4.21
N/A
-0.01
vs -0.01
Q2.22
N/A
-0.01
vs -0.01
Q4.22
N/A
-0.01
vs -0.01
Q2.23
N/A
-0.01
vs -0.01
Q4.23
N/A
-0.00
vs -0.01
Q2.24
N/A
-0.00
vs -0.01
Q4.24
N/A
NA
vs -0.00
Sales Growth
YoY
Current
Estimates
Q2.20
+25%
2.9M vs 2.3M
Q4.20
+26%
3.6M vs 2.8M
Q2.21
+66%
4.8M vs 2.9M
Q4.21
+45%
5.2M vs 3.6M
Q2.22
+11%
5.4M vs 4.8M
Q4.22
+9%
5.7M vs 5.2M
Q2.23
+6%
5.7M vs 5.4M
Q4.23
-15%
4.8M vs 5.7M
Q2.24
-3%
5.5M vs 5.7M
Q4.24
+26%
6M vs 4.8M
Return on Equity
QoQ
Q2.21
-40%
-0.40
vs -0.41
Q4.21
-15%
-0.15
vs -0.40
Q2.22
-21%
-0.21
vs -0.15
Q4.22
-27%
-0.27
vs -0.21
Q2.23
-16%
-0.16
vs -0.27
Q4.23
-19%
-0.19
vs -0.16
Q2.24
-25%
-0.25
vs -0.19
Q4.24
-34%
-0.34
vs -0.25
Institutionnal Ownership
QoQ
Q1.23
1
1
vs 1
NA
Q2.23
1
1
vs 1
NA
Q3.23
1
1
vs 1
NA
Q4.23
1
1
vs 1
NA
Q1.24
1
1
vs 1
NA
Q2.24
1
1
vs 1
NA
Q4.24
1
1
vs NA
NA
Q1.25
1
1
vs 1
NA
Relative Strength
IPD.AX
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
159%2025-Revenue
-45%2025-EPS
-3849%2025-EBITDA
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
Quote Panel
Key Metrics
ImpediMed Limited, a medical software technology company, develops, manufactures, and sells bioimpedance spectroscopy (BIS) devices and software services in Australia, North America, and internationally. The company offers SOZO, a noninvasive BIS device for the assessment of lymphedema and fluid status monitoring of heart failure patients; SFB7, a single-channel, tetrapolar BIS device to analyze body composition in healthy individuals; and ImpediVET, a single-channel, tetrapolar (BIS) device that measures fluid status and tissue composition for veterinary applications. It sells its devices to hospitals and clinics. The company was incorporated in 1999 and is headquartered in Pinkenba, Australia.
ASX
Unprofitable
EPS improving
Unprofitable
EPS improving
Relative Strenght
Volume Buzz
-16%
Earning Acce
No
Dist 52w H.
56%Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How IPD.AX compares to sector?